Literature DB >> 8209755

Electrocardiographic changes following rabbit coronavirus-induced myocarditis and dilated cardiomyopathy.

L K Alexander1, B W Keene, J D Small, B Yount, R S Baric.   

Abstract

Rabbit Coronavirus (RbCV) infection was divided into two phases based upon day of death and pathologic findings. During the acute phase (days 2-5) heart weights (HW) and heart weight-to-body weight (HW/BW) ratios were increased with striking dilation of the right ventricle. These changes as well as increased dilation of the left ventricle were especially pronounced during the subacute phase (days 6-12). Myocytolysis, pulmonary edema, and degeneration and necrosis of myocytes, were seen during both phases. Myocarditis, pleural effusion, calcification of myocytes, and congestion in the liver and lungs were seen in the subacute phase. Electrocardiograms (ECGs) exhibited low voltage, nonspecific ST-T wave changes, sinus tachycardia, occasional ventricular and supraventricular premature complexes and 2(0) AV block consistent with myocarditis and heart failure. Forty-one percent of the survivors exhibited increased HW and HW/BW ratios, biventricular dilation, interstitial and replacement fibrosis, myocyte hypertrophy and myocarditis. ECGs exhibited nonspecific ST-T wave changes, sinus arrhythmia, occasional ventricular and supraventricular premature complexes and 2(0) AV block. These data suggest that RbCV infection may result in viral myocarditis and heart failure with a proportion of survivors progressing into DCM.

Entities:  

Mesh:

Year:  1993        PMID: 8209755     DOI: 10.1007/978-1-4615-2996-5_56

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

Review 1.  Arrhythmia in COVID-19.

Authors:  Savalan Babapoor-Farrokhran; Roozbeh Tarighati Rasekhi; Deanna Gill; Shaghayegh Babapoor; Aman Amanullah
Journal:  SN Compr Clin Med       Date:  2020-08-14

Review 2.  Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection.

Authors:  Yousef Rasmi; Shima Hatamkhani; Roya Naderi; Ameneh Shokati; Vajiheh Nayeb Zadeh; Faezeh Hosseinzadeh; Yeganeh Farnamian; Ladan Jalali
Journal:  Acta Histochem       Date:  2022-05-25       Impact factor: 2.147

3.  Cardiovascular complications of severe acute respiratory syndrome.

Authors:  C-M Yu; R S-M Wong; E B Wu; S-L Kong; J Wong; G W-K Yip; Y O Y Soo; M L S Chiu; Y-S Chan; D Hui; N Lee; A Wu; C-B Leung; J J-Y Sung
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

4.  Molecular screening by polymerase chain reaction detects panleukopenia virus DNA in formalin-fixed hearts from cats with idiopathic cardiomyopathy and myocarditis.

Authors:  K M Meurs; P R Fox; A L Magnon; S Liu; J A Towbin
Journal:  Cardiovasc Pathol       Date:  2000 Mar-Apr       Impact factor: 2.185

5.  Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series.

Authors:  Graham Peigh; Marysa V Leya; Jayson R Baman; Eric P Cantey; Bradley P Knight; James D Flaherty
Journal:  Eur Heart J Case Rep       Date:  2020-05-08

Review 6.  Advances in the relationship between coronavirus infection and cardiovascular diseases.

Authors:  Mengmeng Zhao; Menglong Wang; Jishou Zhang; Jing Ye; Yao Xu; Zhen Wang; Di Ye; Jianfang Liu; Jun Wan
Journal:  Biomed Pharmacother       Date:  2020-05-13       Impact factor: 7.419

Review 7.  Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era.

Authors:  S Greco; A Madè; C Gaetano; Y Devaux; C Emanueli; F Martelli
Journal:  J Transl Med       Date:  2020-10-31       Impact factor: 5.531

8.  Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19.

Authors:  Huayan Xu; Keke Hou; Rong Xu; Zhenlin Li; Hang Fu; Lingyi Wen; Linjun Xie; Hui Liu; Joseph B Selvanayagam; Na Zhang; Zhigang Yang; Ming Yang; Yingkun Guo
Journal:  J Am Heart Assoc       Date:  2020-08-18       Impact factor: 5.501

Review 9.  Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.

Authors:  Samantha L Cooper; Eleanor Boyle; Sophie R Jefferson; Calum R A Heslop; Pirathini Mohan; Gearry G J Mohanraj; Hamza A Sidow; Rory C P Tan; Stephen J Hill; Jeanette Woolard
Journal:  Int J Mol Sci       Date:  2021-07-31       Impact factor: 6.208

Review 10.  SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications.

Authors:  Ossama K Abou Hassan; Calvin C Sheng; Tom Kai Ming Wang; Paul C Cremer
Journal:  Curr Cardiol Rep       Date:  2021-08-03       Impact factor: 2.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.